跳至主要内容
临床试验/NCT04067583
NCT04067583已完成不适用

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey

Bayer1 个研究点 分布在 1 个国家目标入组 454 人开始时间: 2019年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
454
试验地点
1
主要终点
Percentage of physicians responding correctly to each individual knowledge question

研究概览

简要总结

With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Has signed informed consent
  • Is a licensed and practicing ophthalmologist
  • Has prescribed and/or administered aflibercept to at least one patient in the past 6 months

排除标准

  • 未提供

结局指标

主要结局

Percentage of physicians responding correctly to each individual knowledge question

时间窗: Up to 1 year

次要结局

未报告次要终点

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验